An Aston University researcher has developed a new technique using light that could revolutionize non-invasive medical diagnostics and optical communication. The research showcases how a type of light called the orbital angular momentum (OAM) can be harnessed to improve imaging and data transmission through skin and other biological tissues.
Category: biotech/medical – Page 208
Researchers have developed a faster and more accurate method for acquiring and reconstructing high-quality 3D surface measurements. The approach could greatly improve the speed and accuracy of surface measurements used for industrial inspection, medical applications, robotic vision and more.
New research underscores the role of the immune system in depression, linking inflammation to poor response to standard antidepressants and highlighting the importance of personalized medicine in addressing different biological patterns in depressed individuals.
A collaborative study between researchers from the UK and Italy has uncovered new insights into the biological mechanisms of major depressive disorder (MDD), with a particular focus on the role of the immune system.
The researchers examined “gene expression,” which refers to the process by which the instructions in our genes are activated, influencing bodily functions.
A new technique called ‘femtosecond-fieldoscopy’ developed by the Max Planck Institute enables the precise detection of biomarkers in minute liquid quantities using ultrashort laser pulses.
This method provides a clear molecular ‘fingerprint’ for identifying specific molecules and opens up possibilities for advanced biomedical research and applications.
Breakthrough in Biomarker Detection.
Research reveals how antibodies affect brain receptors in patients with anti-NMDAR encephalitis, a condition often misdiagnosed as schizophrenia.
The disease, vividly described in Susannah Cahalan’s memoir “Brain on Fire,” can lead to severe neurological symptoms similar to those of mental health disorders. The study underscores the importance of personalized medicine and improved diagnostics to accurately treat and diagnose this rare disease.
The startling diagnosis of susannah cahalan.
A new study shows that using DNA analysis for newborn screening can detect far more serious, yet treatable, health conditions than traditional methods. The study, called GUARDIAN, is one of the first large-scale projects to use genome sequencing for newborns, and early results suggest that this approach could greatly improve medical care for children.
Early findings from a study on newborn screening reveal that DNA analysis detects significantly more preventable or treatable serious health conditions than traditional screening methods. Most parents offered the option of genome sequencing prefer it.
The study, called GUARDIAN, is among the first large-scale research projects globally to use genome sequencing for newborn screening. It is also the first to release preliminary results.
Over the past decade or so, computer scientists have developed increasingly advanced computational techniques that can tackle real-world tasks with human-comparable accuracy. While many of these artificial intelligence (AI) models have achieved remarkable results, they often do not precisely replicate the computations performed by the human brain.
Researchers at Tibbling Technologies, Broad Institute at Harvard Medical School, The Australian National University and other institutes recently tried to use AI to mimic a specific type of computation performed by circuits in the neocortex, known as “winner-take-all” computations.
Their paper, published on the bioRxiv preprint server, reports the successful emulation of this computation and shows that adding it to transformer-based models could significantly improve their performance on image classification tasks.
Finding ways to connect the human body to technology could have broad applications in health and entertainment. A new “electric plastic” could make self-powered wearables, real-time neural interfaces, and medical implants that merge with our bodies a reality.
While there has been significant progress in the development of wearable and implantable technology in recent years, most electronic materials are hard, rigid, and feature toxic metals. A variety of approaches for creating “soft electronics” has emerged, but finding ones that are durable, power-efficient, and easy to manufacture is a significant challenge.
Organic ferroelectric materials are promising because they exhibit spontaneous polarization, which means they have a stable electric field pointing in a particular direction. This polarization can be flipped by applying an external electrical field, allowing them to function like a bit in a conventional computer.
Estrogen, the major female ovarian hormone, can trigger nerve impulses within milliseconds to regulate a variety of physiological processes. At Baylor College of Medicine, Louisiana State University and collaborating institutions, researchers discovered that estrogen’s fast actions are mediated by the coupling of the estrogen receptor-alpha (ER-alpha) with an ion channel protein called Clic1.
Clic1 controls the fast flux of electrically charged chloride ions through the cell membrane, which neurons use for receiving, conducting and transmitting signals. The researchers propose that interacting with the ER-alpha-Clic1 complex enables estrogen to trigger fast neuronal responses through Clic1 ion currents. The study appears in Science Advances.
“Estrogen can act in the brain to regulate a variety of physiological processes, including female fertility, sexual behaviors, mood, reward, stress response, cognition, cardiovascular activities and body weight balance. Many of these functions are mediated by estrogen binding to one of its receptors, ER-alpha,” said co-corresponding author Dr. Yong Xu, professor of pediatrics—nutrition and associate director for basic sciences at the USDA/ARS Children’s Nutrition Research Center at Baylor.
Science And Engineering For Humanity — Dr. David Agus, MD — Founding Director & Co-CEO, Ellison Institute of Technology.
Dr. David B. Agus (https://davidagus.com/) is one of the world’s leading doctors and pioneering biomedical researchers.
Dr. Agus is the Founding Director and Co-CEO of the Ellison Institute of.
Technology (https://eit.org/) and a professor of medicine (https://keck.usc.edu/faculty-search/d…) and engineering (https://viterbi.usc.edu/directory/fac…) the University of.
Southern California.
A medical oncologist, Dr. Agus leads a multidisciplinary team of researchers.
dedicated to the development and use of technologies to guide doctors in making health-care decisions tailored to individual needs.
An international leader in global health and approaches for personalized healthcare, Dr. Agus serves in leadership roles at the World Economic Forum and is co-chair of the Global Health Security Consortium (https://institute.global/tags/global–…). He is also a CBS News contributor.